CANCELLED: 2020 Phlebology Treatment in Honduras
Care of the patient with debilitating venous disease is common in both the US and in underdeveloped settings. This conference will train physicians to care for patients with this diagnosis with safe, effective and economical methods of sclerotherapy.
The treatment of venous disease is a complex, multifaceted problem. The faculty of this activity will offer detailed instruction through lectures and hands-on training (basic and advanced techniques) in the use of sclerotherapy to address the educational elements along with readings with follow-up discussions.
Intended Audience
This educational activity has been designed to meet the needs of physicains who manage patients with venous disease.
Learning Objectives
Global Learning Objectives:
- Explain basic and advanced prolotherapy and ultrasound guided foam sclerotherapy
- Describe ligament and vein anatomy
- Identify complications and methods to work with ligaments and veins in prolotherapy and foam sclerotherapy
- Identify current research in venous treatment and prolotherapy
Specific Learning Objectives:
- Identify and perform basic prolotherapy techniques
- Gain a thorough knowledge of the anatomy of ligaments
- Comprehend the spectrum of venous insufficiency disease based on the internationally accepted CEAP classification system
- Distinguish the complications and ways to avoid complications when doing prolotherapy and sclerotherapy
- Participate in supervised patient injections of prolotherapy and foam sclerotherapy
- Learn anatomy and common dysfunction of veins
- Recognize the capability and use of duplex U/S for guiding intrafascial injections of incompetent saphenous veins
- Identify and treat venous stasis ulcers
Friday, March 20, 2020 | ||
6:30 | Dinner |
|
7:15-7:30 | Welcome to Honduras | Lindy McHutchison, MD |
7:30-7:45 | Update on Vein Care in Honduras | Meg Spartz, MD |
7:45-8:00 | Safety in Honduras | Shannon Griffin, RN |
|
|
|
Saturday, March 21, 2020 | ||
7:00-8:00 | Breakfast |
|
8:00-9:00 | Leave for Pico Bonito/Excursion/Lunch |
|
9:00-12:00 | Pico Bonito Excursion |
|
PM | ||
12:00-1:00 | Lunch at Pico Bonito |
|
1:00-1:30 | Non-Thermal Non-Tumescent Ablations: Pros and Cons | Paola Ortiz, MD |
1:30-2:00 | U/S Finding – When NOT to Treat the Vein Patient | Agneta Bereczky, RVT, RDMS |
2:00-2:30 | Adhesive Occlusion of Saphenous Veins (AOSV) | Phifer Nicholson, MD |
2:30-3:00 | Lymphatics 101 | Mark Melin, MD |
3:00-3:30 - NO CME credit | Staying Pumped about Pneumatic Compression | Eric Ansart |
3:30-4:00 | Managing and Marketing a Vein Practice | Dvora Nelson, MD |
4:00-5:00 | Return to Hotel La Ceiba |
|
6:30-7:30 | Dinner |
|
7:30-7:50 | Lipedema in Honduras | Lindy McHutchison, MD |
7:50-8:00 | Compression Therapy | Tatiana Zimmerman, RVT |
8:00-8:15 | Specifics about Compression | Tatiana Zimmerman, RVT |
8:15-8:30 | Triage in the Vein Clinic | Shannon Griffin, RN |
8:30-9:00 | HIV/Hep C Test Kits | Mary Doherty, RTR |
9:00-10:00 | Lab: MOCA and AOSV | Paola Ortiz, MD & Phifer Nicholson, MD |
|
|
|
Sunday, March 22, 2020 | ||
7:00-7:45 | Breakfast |
|
7:35-8:00 | Pelvic Congestion Syndrome | Travis Bille, RVT |
8:00-8:25 | D5W – Premise and Pertinence in Phlebology | Lindy McHutchison, MD |
8:25-8:50 | Leg Ulcers – An Overview | Lindy McHutchison, MD |
8:50-9:15 | Latest on the Ulcer Bed: Findings, Prep and Treatment | Mark Melin, MD |
9:15-9:40 | Non-venous Ulcers in Honduras | Carlos Zelaya, MD |
9:40-10:05 | Results – Wound Surfactant on Honduras Leg Ulcer | Carlos Zelaya, MD |
10:05-10:30 | Break (Olanchito folks get bags in lobby) |
|
10:30-11:00 | Load buses – go to Red Cross to sort boxes |
|
11:30 | Olanchito bus leaves for Olanchito |
|
|
|
|
Monday, March 23, 2020 | ||
8:00-12:00 | Clinical Skills Workshop | Lindy McHutchison, MD |
PM |
|
|
1:00-5:00 | Patient Care Workshop | Mark Melin, MD |
7:00-8:00 | Directed Reading discussion | Dvora Nelson, MD |
|
|
|
Tuesday, March 24, 2020 | ||
8:00-12:00 | Clinical Skills Workshop | Meg Spartz, MD |
PM |
|
|
1:00-5:00 | Patient Care Workshop | Phifer Nicholson, MD |
7:00-8:00 | Directed Reading discussion | Paola Ortiz, MD |
|
|
|
Wednesday, March 25, 2020 | ||
8:00-12:00 | Clinical Skills Workshop | Meg Spartz, MD |
PM |
|
|
1:00-5:00 | Patient Care Workshop | Meg Spartz, MD |
7:00-8:00 | Directed Reading discussion | Carlos Zelaya, MD |
|
|
|
Thursday, March 26, 2020 | ||
8:00-12:00 | Clinical Skills Workshop | Lindy McHutchison, MD |
PM |
|
|
1:00-5:00 | Patient Care Workshop | Meg Spartz, MD |
7:00-8:00 | Directed Reading discussion | Meg Spartz, MD |
|
|
|
Friday, March 27, 2020 | ||
8:00-12:00 | Clinical Skills Workshop | Paola Ortiz, MD |
PM |
|
|
1:00-5:00 | Patient Care Workshop | Dvora Nelson, MD |
|
|
|
Saturday, March 28, 2020 | ||
6:00 | Buses Leave for San Pedro Sula Airport |
|
Policy on Disclosure
It is the policy of the University of Wisconsin–Madison ICEP that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). For this educational activity, all conflicts of interests have been resolved and detailed disclosures are listed below:
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation? |
Terese Bailey | Planner | No relevant financial relationships to disclose | No |
Agneta Bereczky, RVT, RDMS | Presenter | No relevant financial relationships to disclose | No |
Travis Bille, RVT | Presenter | No relevant financial relationships to disclose | No |
Mary Doherty, RTR | Planner, Presenter | No relevant financial relationships to disclose | No |
Shannon Griffin, RN | Presenter | No relevant financial relationships to disclose | No |
Lindy McHutchison, MD | Presenter | No relevant financial relationships to disclose | No |
Matthew Melin, MD | Presenter | Sigvaris (Contractor); Tactile Systems Technology Inc. (Contractor); Primus (Contractor) | No |
Dvora Nelson, MD | Presenter | Medtronic (Contractor), Dvora Nelson, Medtronic - Sclerotainer: hands-on sclerotherapy training model (Patent) | No |
Charles Phifer Nicholson, MD | Presenter | Medtronic (Consultant) | No |
Paola Ortiz, MD | Presenter | No relevant financial relationships to disclose | No |
Eric Phillippi, MD | Presenter | No relevant financial relationships to disclose | No |
Margaret (Meg) Spartz, MD | Course Director, Planner, Presenter | No relevant financial relationships to disclose | No |
Michael Weber, MD | Planner, Presenter | No relevant financial relationships to disclose | No |
Carlos Zelaya, MD | Presenter | No relevant financial relationships to disclose | No |
Tatiana Zimmerman, RVT | Presenter | No relevant financial relationships to disclose | No |
* The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) and the Hackett Hemwall Patterson Foundation. The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement
The University of Wisconsin–Madison ICEP designates this live educational activity for a maximum of 52.5 AMA PRA Category1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 5.25 continuing education units (CEUs) or 52.5 hours.
Available Credit
- 52.50 AMA PRA Category 1 Credit™
- 52.50 University of Wisconsin–Madison Continuing Education Hours